TGFBR2 and carcinoma of esophagus: On the contrary, the absence of TGF-β pathway activation also figures as a critical event in some situations, specifically when its signaling pathway disruption is mediated by the lack of Transforming Growth Factor Beta Receptor II (TGFBR2), as observed in colon and esophageal carcinomas [138, 139].